Development Level

Tbio 3 | 10,625
Tchem 3 | 1,890
Tclin 2 | 602

IMPC Term

abnormal behavior 2 | 226
abnormal femur morphology 1 | 14
decreased circulating magnesiu... 1 | 11
increased Ly6C low monocyte nu... 1 | 8

Disease

osteosarcoma 6 | 7,933
ovarian cancer 6 | 8,484
psoriasis 5 | 6,685
Cancer 4 | 2,346
Kidney disease 4 | 396
diabetes mellitus 4 | 1,663
glioblastoma 4 | 5,572
group 4 medulloblastoma 4 | 1,875
lung cancer 4 | 4,466
Alzheimer's disease 3 | 644
Arthritis 3 | 248
Brain disease 3 | 83
Colonic Neoplasms 3 | 126
Heart disease 3 | 279
Hyperglycemia 3 | 120
Lung disease 3 | 132
Mammary Neoplasms 3 | 410
Obesity 3 | 616
Osteoporosis 3 | 257
Parkinson's disease 3 | 364
Reperfusion Injury 3 | 84
Rheumatoid Arthritis 3 | 1,160
Status Epilepticus 3 | 85
Stomach Neoplasms 3 | 282
Toxic encephalopathy 3 | 131
Vascular disease 3 | 281
acute myeloid leukemia 3 | 780
adult high grade glioma 3 | 2,148
atypical teratoid / rhabdoid tumor 3 | 4,369
breast carcinoma 3 | 1,614
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
lung carcinoma 3 | 2,844
medulloblastoma, large-cell 3 | 6,234
non-small cell lung cancer 3 | 2,798
pilocytic astrocytoma 3 | 3,086
tuberculosis 3 | 1,557
ulcerative colitis 3 | 2,087
Asthma 2 | 349
Bladder Neoplasm 2 | 109
Brain Ischemia 2 | 87
Cardiomegaly 2 | 66
Cherubism 2 | 14
Colitis 2 | 46
Eye disease 2 | 55
Fatty liver disease 2 | 84
Gastrointestinal system disease 2 | 50
Heat Stroke 2 | 12
Liver Failure, Acute 2 | 22
Liver disease 2 | 219
Liver neoplasms 2 | 109
Lung Neoplasms 2 | 171
Metabolic syndrome X 2 | 155
Neoplasm Invasiveness 2 | 127
Neoplastic Cell Transformation 2 | 81
Peripheral Neuropathy 2 | 303
acute quadriplegic myopathy 2 | 1,157
cystic fibrosis 2 | 1,665
dermatomyositis 2 | 933
fibroadenoma 2 | 557
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung adenocarcinoma 2 | 2,713
mucosa-associated lymphoid tissue lymphoma 2 | 480
pancreatic cancer 2 | 2,300
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 1,530
ASTHMA, SUSCEPTIBILITY TO (finding) 1 | 6
Acute coronary syndrome 1 | 37
Albuminuria 1 | 20
Arthropathy 1 | 34
Aspergillosis 1 | 23
Berylliosis 1 | 16
Blastic phase chronic myeloid leukemia 1 | 58
Bronchiectasis 1 | 29
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Chronic fatigue syndrome 1 | 29
Chronic phase chronic myeloid leukemia 1 | 45
Cystitis 1 | 16
Diaphragmatic Hernia 1 | 40
Fanconi Anemia 1 | 19
Hemophagocytic lymphohistiocytosis 1 | 30
Insulin Resistance 1 | 48
Leishmaniasis, Visceral 1 | 13
Lichen planus 1 | 17
Lipodystrophy 1 | 32
MALARIA, CEREBRAL, SUSCEPTIBILITY TO (finding) 1 | 3
Noonan Syndrome 1 | 33
Optic atrophy 1 | 43
Oral Submucous Fibrosis 1 | 18
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL 1 | 4
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 1 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 1 | 47
Pneumocystosis 1 | 18
Prostatitis 1 | 15
Reactive arthritis 1 | 7
Retinal Diseases 1 | 21
Sinusitis 1 | 30
Synovitis 1 | 38
Takayasu's arteritis 1 | 52
hemolytic-uremic syndrome 1 | 28

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Non-IDG 4 | 11,971
Kinase 3 | 634
Transcription Factor 1 | 1,400

Grant Application

2R01DK067215-10 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Death-associated protein kinase 2 DAPK2 Tchem Kinase -1.35873 27.0 383
Tumor necrosis factor TNF Tclin Non-IDG -4.68994 50044.6 2261
Proto-oncogene tyrosine-protein kinase Src SRC Tclin Kinase -3.97208 8801.0 1257
Mitochondrial fission factor MFF Tbio Non-IDG -2.20639 163.7 96
Docking protein 4 DOK4 Tbio Non-IDG -1.16186 17.2 160
SH3 domain-binding protein 5 SH3BP5 Tbio Non-IDG -2.70331 512.0 97
Mitogen-activated protein kinase 8 MAPK8 Tchem Kinase -3.75582 5333.9 1016
Transcription factor AP-1 JUN Tchem Transcription Factor -3.80760 5981.8 2262